<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 06/10/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 06/10/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">DORIS EDWARDS</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">August 16, 1936 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>4738 NW 48TH TERRACE<br/>TAMARAC, FL 33319, US<br/><br/>Primary Home Phone:  954-991-8149<br/>Mobile Phone:  954-991-8149<br/>Email:  nadpat_t@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">73937 2.16.840.1.113883.4.391.330529<br/>73937 2.16.840.1.113883.4.391.330529.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">fc0418dd-0105-46b8-a57d-83384b51e7a9 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">October 11, 2024, 15:11:43 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">EVEROLD HAFFIZULLA</td></tr><tr><td class="td_header_role_value internal_format">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">JASON HAFFIZULLA</td></tr><tr><td class="td_header_role_value internal_format">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">1057996 2.16.840.1.113883.4.391.330529</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From June 10, 2024, 14:30:00   to June 10, 2024, 14:45:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.330529</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">JASON HAFFIZULLA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">DORIS EDWARDS<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  954-991-8149<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">JASON HAFFIZULLA signed at June 10, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Medical Associates Of Tamarac Pa</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">REASON FOR VISIT</a></li><li><a href="#id2">MEDICATIONS</a></li><li><a href="#id3">VITAL SIGNS</a></li><li><a href="#id4">Encounters</a></li><li><a href="#id5">ASSESSMENTS</a></li><li><a href="#id6">PLAN OF TREATMENT</a></li><li><a href="#id7">Progress Notes</a></li><li><a href="#id8">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">REASON FOR VISIT</a></h3><div>follow-up after hospital stay</div><h3><a name="id2" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Nirmatrelvir&amp;Ritonavir 300/100 20 x 150 MG &amp; 10 x 100MG</td><td ID="instruction1">as directed Orally as directed for 5 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Advair HFA 230-21 MCG/ACT</td><td ID="instruction2">INHALE 2 PUFFS INTO THE LUNGS TWICE A DAY FOR 30 DAYS for 30</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication3">Omeprazole 40 MG</td><td ID="instruction3">TAKE 1 CAPSULE BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication4">NIFEdipine ER 60 MG</td><td ID="instruction4">TAKE 1 TABLET BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication5">Nirmatrelvir&amp;Ritonavir 300/100 20 x 150 MG &amp; 10 x 100MG</td><td ID="instruction5">as directed Orally as directed for 5 days</td><td/><td>12/22/2023</td><td/><td>Not-Taking</td></tr><tr><td ID="medication6">predniSONE 20 MG</td><td ID="instruction6">TAKE 3 TABLETS BY MOUTH EVERY DAY Oral for 3 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">ALBUTEROL(V) HFA 200 INH 108.000</td><td ID="instruction7"/><td ID="medication7notes">ALBUTEROL(V) HFA 200 INH *Reorder from Medispan for eRx and Interaction Alerts*</td><td>11/01/2022</td><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Advair HFA 230-21 MCG/ACT</td><td ID="instruction8">2 puffs Inhalation Twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Benzonatate 100 MG</td><td ID="instruction9">1 capsule as needed Orally Three times a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Albuterol Sulfate (2.5 MG/3ML) 0.083%</td><td ID="instruction10">3 mL as needed Inhalation every 6 hrs</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Clopidogrel Bisulfate 75 MG</td><td ID="instruction11">TAKE 1 TABLET BY MOUTH EVERY DAY Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">NIFEdipine ER 30 MG</td><td ID="instruction12">1 tablet on an empty stomach Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Flonase Sensimist 27.5 MCG/SPRAY</td><td ID="instruction13">2 sprays (1 spray in each nostril) Nasally Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Symbicort 160-4.5 MCG/ACT</td><td ID="instruction14">2 puffs Inhalation Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication15">Rosuvastatin Calcium 20 MG</td><td ID="instruction15">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication16">Augmentin 500-125 MG</td><td ID="instruction16">1 tablet Orally TWICE DAILY for 10 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication17">Doxycycline</td><td ID="instruction17"/><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id3" href="#toc">VITAL SIGNS</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.2 degrees Fahrenheit</td><td>06/10/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>110 mm Hg</td><td>06/10/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>70 mm Hg</td><td>06/10/2024</td></tr><tr><th ID="vital4">Height</th><td>64 in</td><td>06/10/2024</td></tr><tr><th ID="vital5">Weight</th><td>141 lbs</td><td>06/10/2024</td></tr><tr><th ID="vital6">BMI</th><td>24.2 kg/m2</td><td>06/10/2024</td></tr><tr><th ID="vital7">Height-cm</th><td>162.56 cm</td><td>06/10/2024</td></tr><tr><th ID="vital8">Weight-kg</th><td>63.96 kg</td><td>06/10/2024</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Medical Associates Of Tamarac Pa</td><td>7875 W COMMERCIAL BLVD TAMARAC, FL 33351-4353</td><td>06/10/2024</td><td>JASON HAFFIZULLA</td><td>Vitamin D deficiency, unspecified E55.9 ; Chronic obstructive pulmonary disease, unspecified J44.9 ; Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side I69.954 ; Uterovaginal prolapse, unspecified N81.4 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Mixed hyperlipidemia E78.2 ; Gastro-esophageal reflux disease with esophagitis, without bleeding K21.00 ; Frontal sinusitis, unspecified chronicity J32.1 ; Other thrombophilia D68.69 ; Chronic kidney disease, stage 3a N18.31 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 and Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, unspecified whether long term insulin use E11.51</td></tr></tbody></table></div><h3><a name="id5" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">06/10/2024</td><td>Vitamin D deficiency, unspecified (ICD-10 - E55.9)</td><td>Mig-1624898-</td><td>conrlled on vitamin D supplement</td><td/></tr><tr><td ID="ref2">06/10/2024</td><td>Chronic obstructive pulmonary disease, unspecified (ICD-10 - J44.9)</td><td>Mig-1624898-</td><td>controlled on ventolin contrlled on symbicort</td><td/></tr><tr><td ID="ref3">06/10/2024</td><td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side (ICD-10 - I69.954)</td><td>Mig-1624898-</td><td><p>post vertigo and DR ISHMAEL</p><p>MRI AND EEG RESULTS</p><p>3 MO controlled on increased walking exercises</p></td><td/></tr><tr><td ID="ref4">06/10/2024</td><td>Uterovaginal prolapse, unspecified (ICD-10 - N81.4)</td><td>Mig-1624898-dr black</td><td>treated with pelvic exercises and controlled therein. follow with urigynoceolgy treated with pessary and stable</td><td/></tr><tr><td ID="ref5">06/10/2024</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td>Mig-1624898-</td><td>contrllled on glizipide for dm and hyperlipdemia, due to dm controlled with creastor</td><td/></tr><tr><td ID="ref6">06/10/2024</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>Mig-1624898-</td><td>controlled on crestor</td><td/></tr><tr><td ID="ref7">06/10/2024</td><td>Gastro-esophageal reflux disease with esophagitis, without bleeding (ICD-10 - K21.00)</td><td>Mig-1624898-</td><td>conrlled onfamotdiine</td><td/></tr><tr><td ID="ref8">06/10/2024</td><td>Frontal sinusitis, unspecified chronicity (ICD-10 - J32.1)</td><td/><td>controlled on flonase</td><td/></tr><tr><td ID="ref9">06/10/2024</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td>due to diabetes and conrolled on plavix</td><td/></tr><tr><td ID="ref10">06/10/2024</td><td>Chronic kidney disease, stage 3a (ICD-10 - N18.31)</td><td/><td>controlled on increased fluid intake</td><td/></tr><tr><td ID="ref11">06/10/2024</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td>controlled on glipizide for dm and ckd, due to dm, controlled on increased fluid intake</td><td/></tr><tr><td ID="ref12">06/10/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td/><td>htn controlled on nifedipine and ckd due to htn controleld on increased fluid intake</td><td/></tr><tr><td ID="ref13">06/10/2024</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, unspecified whether long term insulin use (ICD-10 - E11.51)</td><td/><td>controlled on glipizide for diabetes and on plavix and walking exercises for peripheral angiopathy. </td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Nirmatrelvir&amp;Ritonavir 300/100 20 x 150 MG &amp; 10 x 100MG</td><td>as directed Orally as directed for 5 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Advair HFA 230-21 MCG/ACT</td><td>2 puffs Inhalation Twice a day for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds3">Benzonatate 100 MG</td><td>1 capsule as needed Orally Three times a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds4">Albuterol Sulfate (2.5 MG/3ML) 0.083%</td><td>3 mL as needed Inhalation every 6 hrs</td><td/><td/><td/></tr><tr><td ID="potMeds5">NIFEdipine ER 30 MG</td><td>1 tablet on an empty stomach Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds6">Flonase Sensimist 27.5 MCG/SPRAY</td><td>2 sprays (1 spray in each nostril) Nasally Once a day for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds7">Symbicort 160-4.5 MCG/ACT</td><td>2 puffs Inhalation Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds8">Rosuvastatin Calcium 20 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds9">Augmentin 500-125 MG</td><td>1 tablet Orally TWICE DAILY for 10 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Vitamin D deficiency, unspecified</td><td>conrlled on vitamin D supplement</td></tr><tr><td ID="instructionpot2">Chronic obstructive pulmonary disease, unspecified</td><td>controlled on ventolin contrlled on symbicort</td></tr><tr><td ID="instructionpot3">Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side</td><td><p>post vertigo and DR ISHMAEL</p><p>MRI AND EEG RESULTS</p><p>3 MO controlled on increased walking exercises</p></td></tr><tr><td ID="instructionpot4">Uterovaginal prolapse, unspecified</td><td>treated with pelvic exercises and controlled therein. follow with urigynoceolgy treated with pessary and stable</td></tr><tr><td ID="instructionpot5">Type 2 diabetes mellitus with other specified complication</td><td>contrllled on glizipide for dm and hyperlipdemia, due to dm controlled with creastor</td></tr><tr><td ID="instructionpot6">Mixed hyperlipidemia</td><td>controlled on crestor</td></tr><tr><td ID="instructionpot7">Gastro-esophageal reflux disease with esophagitis, without bleeding</td><td>conrlled onfamotdiine</td></tr><tr><td ID="instructionpot8">Frontal sinusitis, unspecified chronicity</td><td>controlled on flonase</td></tr><tr><td ID="instructionpot9">Other thrombophilia</td><td>due to diabetes and conrolled on plavix</td></tr><tr><td ID="instructionpot10">Chronic kidney disease, stage 3a</td><td>controlled on increased fluid intake</td></tr><tr><td ID="instructionpot11">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td>controlled on glipizide for dm and ckd, due to dm, controlled on increased fluid intake</td></tr><tr><td ID="instructionpot12">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>htn controlled on nifedipine and ckd due to htn controleld on increased fluid intake</td></tr><tr><td ID="instructionpot13">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, unspecified whether long term insulin use</td><td>controlled on glipizide for diabetes and on plavix and walking exercises for peripheral angiopathy. </td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">LIPID PANEL, STANDARD (7600)</td><td>06/10/2024</td></tr><tr><td ID="pendingTest2">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>06/10/2024</td></tr><tr><td ID="pendingTest3">CBC (INCLUDES DIFF/PLT) (6399)</td><td>06/10/2024</td></tr><tr><td ID="pendingTest4">HEMOGLOBIN A1c (496)</td><td>06/10/2024</td></tr><tr><td ID="pendingTest5">TSH (899)</td><td>06/10/2024</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 2 Months, Reason: </td></tr></tbody></table></div><h3><a name="id7" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>EDWARDS, DORIS <span class="bold">DOB:</span> 08/16/1936 (87 yo F) <span class="bold">Acc No.</span> 73937 <span class="bold">DOS:</span> 06/10/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>EDWARDS, DORIS<br/><span class="bold">Account Number: </span>73937</td><td align="right"><span class="bold">Provider: </span>Jason Haffizulla, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>08/16/1936<span class="bold">   Age: </span>87 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>06/10/2024</td></tr><tr><td><span class="bold">Phone: </span>347-556-4965</td></tr><tr><td colspan="2"><span class="bold">Address: </span>4738 NW 48TH TERRACE, TAMARAC, FL-33319</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Follow-up after hospital stay. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Activities of Daily Living</span>: <br/>       has been having a chronic cough that has not improved since she began antibiotics. yellow productive sputum.<br/>       and Annual Wellness Visit.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      Patient denies hives,  itching,  rash, hives,  itching,  rash.   <br/>   <span class="Underline">Ophthalmologic</span>: <br/>      Patient denies blurry vision,  discharge,  red eye(s), blurry vision,  discharge,  red eye(s). Patient complains of double vision.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Patient denies cold intolerance,  hair loss,  irregular menses, cold intolerance,  hair loss,  irregular menses.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Patient denies chronic cough,  shortness of breath,  sputum production, chronic cough,  shortness of breath,  sputum production.   <br/>   <span class="Underline">Breast</span>: <br/>      Patient denies bloody nipple discharge,  breast pain,  breast swelling, bloody nipple discharge,  breast pain,  breast swelling.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Patient denies chest pain,  chest pain with exertion,  irregular heartbeat, chest pain,  chest pain with exertion,  irregular heartbeat.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Patient denies abdominal pain,  diarrhea,  rectal bleeding, abdominal pain,  diarrhea,  rectal bleeding.   <br/>   <span class="Underline">Hematology</span>: <br/>      Patient denies easy bleeding,  easy bruising,  recent transfusion, easy bleeding,  easy bruising,  recent transfusion.   <br/>   <span class="Underline">Gynecology</span>: <br/>      Patient denies abnormal bleeding,  hot flashes,  pelvic pain, abnormal bleeding,  hot flashes,  pelvic pain.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Patient denies abdominal pain / swelling,  blood in the urine,  frequent urination, abdominal pain / swelling,  blood in the urine,  frequent urination.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Patient denies arthritis / arthralgia,  joint stiffness,  swollen joints, arthritis / arthralgia,  joint stiffness,  swollen joints.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Patient denies blanching of skin,  cold extremities,  decreased sensation in extremities, blanching of skin,  cold extremities,  decreased sensation in extremities.   <br/>   <span class="Underline">Podiatric</span>: <br/>      Patient denies ankle pain,  foot pain,  sole pain, ankle pain,  foot pain,  sole pain.   <br/>   <span class="Underline">Skin</span>: <br/>      Patient denies blistering of skin,  changing moles,  skin lesion(s), blistering of skin,  changing moles,  skin lesion(s).   <br/>   <span class="Underline">Neurologic</span>: <br/>      Patient denies dizziness,  gait abnormality,  headache, dizziness,  gait abnormality,  headache. - dizziness off and on for last 2 weeks,no fall ,no headache,lasts for munutes when gets up grom bed,no nausea.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Patient denies delusions,  depressed mood,  difficulty sleeping, delusions,  depressed mood,  difficulty sleeping.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Doxycycline      , Taking NIFEdipine ER 60 MG Tablet Extended Release 24 Hour 1 tablet on an empty stomach Orally Once a day , Taking Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day , Taking Benzonatate 100 MG Capsule 1 capsule as needed Orally Three times a day , Taking Clopidogrel Bisulfate 75 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral  , Taking predniSONE 20 MG Tablet TAKE 3 TABLETS BY MOUTH EVERY DAY Oral  , Not-Taking Advair HFA 230-21 MCG/ACT Aerosol 2 puffs Inhalation Twice a day , Not-Taking ALBUTEROL(V) HFA 200 INH 108.000 aerosol    , Notes to Pharmacist: ALBUTEROL(V) HFA 200 INH *Reorder from Medispan for eRx and Interaction Alerts*, Not-Taking Symbicort 160-4.5 MCG/ACT Aerosol 2 puffs Inhalation Twice a day , Not-Taking Flonase Sensimist 27.5 MCG/SPRAY Suspension 2 sprays (1 spray in each nostril) Nasally Once a day , Not-Taking Nirmatrelvir&amp;Ritonavir 300/100 20 x 150 MG &amp; 10 x 100MG Tablet Therapy Pack as directed Orally as directed , Not-Taking Nirmatrelvir&amp;Ritonavir 300/100 20 x 150 MG &amp; 10 x 100MG Tablet Therapy Pack as directed Orally as directed , Not-Taking Albuterol Sulfate (2.5 MG/3ML) 0.083% Nebulization Solution 1 ampule Inhalation every 6 hrs , Not-Taking NIFEdipine ER 60 MG Tablet Extended Release 24 Hour TAKE 1 TABLET BY MOUTH EVERY DAY   , Not-Taking Advair HFA 230-21 MCG/ACT Aerosol INHALE 2 PUFFS INTO THE LUNGS TWICE A DAY FOR 30 DAYS   , Not-Taking Omeprazole 40 MG Capsule Delayed Release TAKE 1 CAPSULE BY MOUTH EVERY DAY   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP: 110/70 mm Hg, Temp: 97.2 F, Wt: 141 lbs, Wt-kg: 63.96 kg, Ht: 64 in, Ht-cm: 162.56 cm, BMI: 24.2 Index, Body Surface Area: 1.7.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, well-nourished and in no acute distress , alert, pleasant, well-nourished and in no acute distress. <br/>      Head: normocephalic, atraumatic , normocephalic, atraumatic. <br/>      Ears: normal , normal. <br/>      Oral cavity: normal, with good dentition , normal, with good dentition. <br/>      Throat: clear, no erythema , clear, no erythema. <br/>      Neck / thyroid: carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy , carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy. <br/>      Lymph nodes: no axillary, supraclavicular or inguinal lymphadenopathy , no axillary, supraclavicular or inguinal lymphadenopathy. <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution , skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop , regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes , clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Chest: chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion , chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion. <br/>      Abdomen: soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly , soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly. <br/>      Musculoskeletal: hemiplegia left side due to cva. <br/>      Peripheral pulses: decreased BLE pulses. <br/>      Neurologic: nonfocal, alert and oriented, cognitive exam grossly normal, deep tendon reflexes 2+ symmetrical , left hemiplegia and hemiparesis due to cva.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Chronic obstructive pulmonary disease, unspecified - J44.9 (Primary), Mig-1624898- 2. Vitamin D deficiency, unspecified - E55.9, Mig-1624898- 3. Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side - I69.954, Mig-1624898- 4. Uterovaginal prolapse, unspecified - N81.4, Mig-1624898-dr black 5. Type 2 diabetes mellitus with other specified complication - E11.69, Mig-1624898- 6. Mixed hyperlipidemia - E78.2, Mig-1624898- 7. Gastro-esophageal reflux disease with esophagitis, without bleeding - K21.00, Mig-1624898- 8. Frontal sinusitis, unspecified chronicity - J32.1 9. Other thrombophilia - D68.69 10. Chronic kidney disease, stage 3a - N18.31 11. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22 12. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I12.9 13. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, unspecified whether long term insulin use - E11.51 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Chronic obstructive pulmonary disease, unspecified</span> <br/>Refill Symbicort Aerosol, 160-4.5 MCG/ACT, 2 puffs, Inhalation, Twice a day, 90 days, Refills 0.  <br/>Notes: controlled on ventolin contrlled on symbicort  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Vitamin D deficiency, unspecified</span> <br/>Start Albuterol Sulfate Nebulization Solution, (2.5 MG/3ML) 0.083%, 3 mL as needed, Inhalation, every 6 hrs; Start Nirmatrelvir&amp;Ritonavir 300/100 Tablet Therapy Pack, 20 x 150 MG &amp; 10 x 100MG, as directed, Orally, as directed, 5 days, 30 tablets, Refills 0.  <br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: TSH (899)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>Notes: conrlled on vitamin D supplement  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side</span> <br/>Notes: post vertigo and DR ISHMAEL<br/>MRI AND EEG RESULTS<br/>3 MO controlled on increased walking exercises  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Uterovaginal prolapse, unspecified</span> <br/>Notes: treated with pelvic exercises and controlled therein. follow with urigynoceolgy treated with pessary and stable  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Type 2 diabetes mellitus with other specified complication</span> <br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: TSH (899)</span><br/>Notes: contrllled on glizipide for dm and hyperlipdemia, due to dm controlled with creastor  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Mixed hyperlipidemia</span> <br/>Refill Rosuvastatin Calcium Tablet, 20 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 0.  <br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: TSH (899)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>Notes: controlled on crestor  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Gastro-esophageal reflux disease with esophagitis, without bleeding</span> <br/>Notes: conrlled onfamotdiine  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Frontal sinusitis, unspecified chronicity</span> <br/>Notes: controlled on flonase  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Other thrombophilia</span> <br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>     <span class="Underline">LAB: TSH (899)</span><br/>Notes: due to diabetes and conrolled on plavix  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Chronic kidney disease, stage 3a</span> <br/>     <span class="Underline">LAB: TSH (899)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>Notes: controlled on increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>     <span class="Underline">LAB: TSH (899)</span><br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Notes: controlled on glipizide for dm and ckd, due to dm, controlled on increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Notes: htn controlled on nifedipine and ckd due to htn controleld on increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, unspecified whether long term insulin use</span> <br/>Notes: controlled on glipizide for diabetes and on plavix and walking exercises for peripheral angiopathy.   </td></tr><tr><td/></tr><tr><td><span class="bold">14. Others </span> <br/>Start Augmentin Tablet, 500-125 MG, 1 tablet, Orally, TWICE DAILY, 10 days, 20, Refills 1; Refill NIFEdipine ER Tablet Extended Release 24 Hour, 30 MG, 1 tablet on an empty stomach, Orally, Once a day, 90 days, 90 Tablet, Refills 5; Start Flonase Sensimist Suspension, 27.5 MCG/SPRAY, 2 sprays (1 spray in each nostril), Nasally, Once a day, 30 days, 1 each, Refills 1; Start Advair HFA Aerosol, 230-21 MCG/ACT, 2 puffs, Inhalation, Twice a day, 30 days, 1 each, Refills 0; Start Benzonatate Capsule, 100 MG, 1 capsule as needed, Orally, Three times a day, 90 days, 270 Capsule, Refills 0.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1111F DSCHRG MED/CURRENT MED MERGE, 3078F DIAST BP &lt; 80 MM HG, 3074F SYST BP LT 130 MM HG, 3008F BODY MASS INDEX DOCD, 71046 X-RAY EXAM CHEST 2 VIEWS</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 2 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1111F DSCHRG MED/CURRENT MED MERGE. <br/>3078F DIAST BP &lt; 80 MM HG. <br/>3074F SYST BP LT 130 MM HG. <br/>3008F BODY MASS INDEX DOCD. <br/>71046 X-RAY EXAM CHEST 2 VIEWS. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by JASON HAFFIZULLA , MD  on 06/11/2024 at 04:56 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Jason Haffizulla, MD</td><td align="right"><span class="bold">Date: </span>06/10/2024</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id8" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="15">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, well-nourished and in no acute distress , alert, pleasant, well-nourished and in no acute distress</td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic , normocephalic, atraumatic</td></tr><tr><td>Ears:</td><td colspan="2">normal , normal</td></tr><tr><td>Throat:</td><td colspan="2">clear, no erythema , clear, no erythema</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy , carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop , regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop</td></tr><tr><td>Chest:</td><td colspan="2">chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion , chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes , clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly , soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly</td></tr><tr><td>Neurologic:</td><td colspan="2">nonfocal, alert and oriented, cognitive exam grossly normal, deep tendon reflexes 2+ symmetrical , left hemiplegia and hemiparesis due to cva</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution , skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr><tr><td>Peripheral pulses:</td><td colspan="2">decreased BLE pulses</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">hemiplegia left side due to cva</td></tr><tr><td>Lymph nodes:</td><td colspan="2">no axillary, supraclavicular or inguinal lymphadenopathy , no axillary, supraclavicular or inguinal lymphadenopathy</td></tr><tr><td>Oral cavity:</td><td colspan="2">normal, with good dentition , normal, with good dentition</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>